Ommeena Pharma Distributors Profile
Key Indicators
- Authorised Capital ₹ 5.50 Cr
as on 13-12-2024
- Paid Up Capital ₹ 5.25 Cr
as on 13-12-2024
- Company Age 6 Year, 7 Months
- Last Filing with ROC 31 Mar 2022
- Open Charges ₹ 11.36 Cr
as on 13-12-2024
- Satisfied Charges ₹ 5.00 M
as on 13-12-2024
- Revenue 43.93%
(FY 2022)
- Profit 42.90%
(FY 2022)
- Ebitda 43.92%
(FY 2022)
- Net Worth 32.16%
(FY 2022)
- Total Assets 118.98%
(FY 2022)
About Ommeena Pharma Distributors
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 5.50 Cr and a paid-up capital of Rs 5.25 Cr.
The company currently has active open charges totaling ₹11.36 Cr. The company has closed loans amounting to ₹5.00 M, as per Ministry of Corporate Affairs (MCA) records.
Raja Shanmuganathan and Ashok Kumar serve as directors at the Company.
- CIN/LLPIN
U33112TN2018PTC122359
- Company No.
122359
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
26 Apr 2018
- Date of AGM
30 Sep 2022
- Date of Balance Sheet
31 Mar 2022
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Company Details
- Location
Chennai, Tamil Nadu, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Ommeena Pharma Distributors?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Raja Shanmuganathan  | Managing Director | 27-Aug-2018 | Current |
Board Members(1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Ashok Kumar | Director | 02-Feb-2019 | Current |
Financial Performance of Ommeena Pharma Distributors.
Ommeena Pharma Distributors Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 43.93% increase. The company also saw a substantial improvement in profitability, with a 42.9% increase in profit. The company's net worth Soared by an impressive increase of 32.16%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Ommeena Pharma Distributors?
In 2022, Ommeena Pharma Distributors had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Forecare Pharmaceuticals Private LimitedActive 9 years 10 months
Raja Shanmuganathan is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Tamilnad Mercantile Bank Limited Creation Date: 31 Jan 2022 | ₹6.40 M | Open |
Tamilnad Mercantile Bank Limited Creation Date: 24 Dec 2021 | ₹4.39 M | Open |
Axis Bank Limited Creation Date: 18 Dec 2021 | ₹2.19 Cr | Open |
How Many Employees Work at Ommeena Pharma Distributors?
Ommeena Pharma Distributors has a workforce of 18 employees as of Apr 03, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ommeena Pharma Distributors, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ommeena Pharma Distributors's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
